Lior Carmon PhD

Lior Carmon is an immunologist and Vaccine expert with extensive experience in the biotech industry. Currently, he is the owner of BIM, a boutique management consulting firm specializing in immunology-related R&D. He founded VaxilBio and developed the ImMucin™ cancer vaccine, which is now in phase 2 clinical trials. Additionally, he co-founded Biokine and played a key role in the development of its lead product for stem cell mobilization. Lior Carmon excels in corporate strategy, financing, investor relations, and company operations, with a focus on R&D, business development, clinical trials, and IP management. He holds numerous granted patents and has authored multiple publications, showcasing his expertise in immunology, Vaccinology, biochemistry, molecular biology, cell biology, and peptide chemistry. Lior's educational background includes a PhD in Tumor Immunology and Immunotherapy, executive studies for CEOs, and an MBA in International Marketing.